Kevin G. Pollock PhD

Kevin Pollock currently serves as Director of Real World Evidence at Eli Lilly. Prior to joining Lilly, he held the same position at Bristol Myers Squibb. Before that, he was the lead healthcare epidemiologist for the Scottish Human Papilloma Virus (HPV) program including the quantitative and qualitative analysis of data using statistical techniques. His role included lecturing duties at Glasgow, Strathclyde, and Edinburgh University. With over 20 years of experience in the area of vaccines, vaccination, and real-world data analysis Kevin is mission-driven and has a great aptitude for thinking differently about how to combine clinical and non-clinical data for evaluating a particular vaccination program.

In addition to his job duties, Kevin served on the Board of Trustees for Jo’s Cervical Cancer Trust – the only UK charity dedicated to women affected by cervical cancer.

He received his PhD in Biochemistry and Immunology from the University of Glasgow in 2006 followed by a 2-year PostDoc on “Vaccine adjuvants and the ability to manipulate the host immune response”. From 2016 to 2020 he was an honorary Lecturer in Infection, Immunity, and Inflammation at his alma mater.